Loading clinical trials...
Loading clinical trials...
This purpose of this study is to measure the concentrations of two anti-epileptic drugs (Eslicarbazepine acetate and oxcarbazepine) and their metabolites in the cerebrospinal fluid and blood plasma of...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Bial - Portela C S.A.
NCT01273129 · Epilepsy, Epilepsy, Temporal Lobe, and more
NCT05067634 · Partial Epilepsy
NCT04903314 · Partial Epilepsy
NCT00465517 · Partial Epilepsy, Catamenial Epilepsy
NCT02076698 · Partial Epilepsy, Surgery
SGS LSS Clinical Pharmacology Unit Antwerpen
Antwerp
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions